Results 51 to 60 of about 9,765 (178)
a novel variant of gene in a neonate with congenital hypoparathyroidism [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2018 Autosomal-dominant hypocalcemia with hypercalciuria (ADHH) is a genetic disease characterized by hypoparathyroidism with hypercalciuria. Most patients with ADHH have calcium-sensing receptor (CaSR) gene mutations.
Jung-Eun Moon +5 more
doaj +1 more source
Food Science &Nutrition, Volume 14, Issue 4, April 2026.This study investigated the association between serum 25‐hydroxyvitamin D [25(OH)D] levels and mortality risk in 4681 patients with overactive bladder (OAB) from the 2005 to 2018 NHANES cohort. Restricted cubic spline analysis revealed a non‐linear dose–response relationship, namely an L‐shaped association with all‐cause mortality (threshold: 66.82 ...
Chao Yang +6 more
wiley +1 more source
Screening of hypercalciuria among children with persistent asymptomatic hematuria
Journal of Biostatistics and Epidemiology, 2018 Background & Aim: Hypercalciuria is commonly observed in accompany with some conditions. Hypercalciuria can clinically present different symptoms and signs. The diagnostic methods for hypercalciuria have not yet been standardized. The presented study was
Mohsen Akhavansepahi +2 more
doaj
Endokrynologia PolskaINTRODUCTION: Nephrolithiasis is a common complication of primary hyperparathyroidism (PHPT), but the mechanisms underlying stone formation remain incompletely understood.
Michał Popow +4 more
doaj +1 more source
Metabolic evaluation in patients with nephrolithiasis: A report from Isfahan, Iran
Advanced Biomedical Research, 2012 Background: Nephrolithiasis is a major public health problem worldwide. In recent years, growing evidence suggest that this disease may originate from underlying metabolic disorders.
Afsoon Emami-Naini +7 more
doaj +1 more source
Identifying recurrent stone formers with machine learning: A single‐centre observational study
BJUI Compass, Volume 7, Issue 3, March 2026.Abstract Objectives Kidney stones affect 12% of the population over their lifetime. Recurrent kidney stones lead to repeated interventions and excessive healthcare costs. Despite progress in imaging and metabolic evaluations, models to accurately identify patients at high risk are missing.
Pedro Amado +7 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 3, March 2026.ABSTRACT Introduction The European Summary of Product Characteristics (SmPC) for 5‐FU warns of significant granulocyte decline when combined with thiazides, cyclophosphamide, or methotrexate, based on a 1981 cohort of 14 patients. Despite limited evidence, drug‐interaction checkers still flag this risk.
Gerard Ronda‐Roca +5 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT Gitelman syndrome (GS) is a rare autosomal recessive tubulopathy characterized by hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria. A 27‐year‐old woman presented with a witnessed syncopal episode, progressive weakness, and nausea.
Iyassu S. Melkie +5 more
wiley +1 more source
Archives of Clinical and Experimental Surgery, 2017 Background: Preventing the recurrence of episodes of stone formation is the focus of interest for patients. This retrospective study aimed to determine the prevalence of metabolic abnormalities and anatomical alterations of the genitourinary tract in ...
John Neil, Jose Binu
doaj +1 more source